| 產品編號 | IHC0280 |
| 英文名稱 | Bcl-2 Ready-To-Use IHC Kit |
| 中文名稱 | Bcl-2即用型免疫組化試劑盒 |
| 別 名 | AW986256; Bcl-2; BCL2; C430015F12Rik; D630044D05Rik; D830018M01Rik; PPP1R50; Apoptosis regulator Bcl 2; B cell leukemia/lymphoma 2 |
| 保存條件 | Please store components at the temperatures indicated on the individual tube labels. The kit is stable for 6 months from the date of receipt. |
| 產品介紹 |
BCL-2 is a key regulator of apoptosis that functions to either inhibit or promote cell death. The BCL-2 family members are also characterized by dimerizing to further modulate apoptosis. Bag1, for example, has been found to form a heterodimer with BCL-2 resulting in the enhancement of the anti-apoptotic effect of BCL-2. Bax and Bak have been shown to play a critical role in cytochrome c release from mitochondria and thus initiate apoptosis. Bax exerts a pro-apoptotic rather than an anti-apoptotic effect on cells. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. In most follicular lymphomas, neoplastic germinal centers express high levels of BCL-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Two transcript variants of BCL-2, produced by alternate splicing, differ in their C-terminal ends. The overexpression of BCL-2 has been linked to human cancers such as B-cell lymphoma and prostate cancer. |
| 產品圖片 |
Immunohistochemical analysis of paraffin embedded mouse spleen tissue slide using IHC0280 (Bcl-2 IHC Kit).
Immunohistochemical analysis of paraffin embedded human spleen tissue slide using IHC0280 (Bcl-2 IHC Kit).
Immunohistochemical analysis of paraffin embedded human tonsil tissue slide using IHC0280 (Bcl-2 IHC Kit).
Immunohistochemical analysis of paraffin embedded rat spleen tissue slide using IHC0280 (Bcl-2 IHC Kit).
|
| 1、抗體溶解方法 | |
| 2、抗體修復方式 | |
| 3、常用試劑的配制 | |
| 4、免疫組化操作步驟 | |
| 5、免疫組化問題解答 | |
| 6、Western Blotting 操作步驟 | |
| 7、Western Blotting 問題解答 | |
| 8、關于肽鏈的設計 | |
| 9、多肽的溶解與保存 | |
| 10、酶標抗體效價測定程序 | |
